iTonic (ITOC) vs Neuraxis (NRXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuraxis (NRXS) has outperformed iTonic (ITOC) over the past year, gaining 127.1% versus a loss of 64.9%. Neuraxis is the larger company by market cap ($85.5 million vs $29.8 million), about 2.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITOC | NRXS |
|---|---|---|
| Share price | $4.08 | $6.81 |
| Market cap | $29.81M | $85.46M |
| 1-day change | -1.81% | -0.37% |
| YTD return | -38.39% | +50.44% |
| 1-year return | -64.90% | +127.14% |
| EPS (TTM) | $-4.22 | $-0.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $9.33 |
| 52-week low | $3.42 | $2.21 |
| Distance from 52-week high | -77.85% | -27.06% |
| Average volume | 51.11K | 107.18K |
| Shares outstanding | 6.84M | 12.56M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Neuraxis is about 2.9 times larger than iTonic by market value ($85.46M vs $29.81M).
- NRXS has outperformed ITOC by 192.0 percentage points over the past year.
ITOC vs NRXS FAQ
Which is bigger, iTonic or Neuraxis?
Neuraxis (NRXS) is larger, with a market capitalization of $85.46M compared with $29.81M for iTonic (ITOC).
Which stock has performed better over the past year, ITOC or NRXS?
NRXS returned +127.14% over the past 12 months, compared with -64.90% for ITOC (price return, excluding dividends). Past performance does not predict future results.
Are iTonic and Neuraxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.